SUPPLY CHAIN
companies simply cannot afford climate impacts that reduce resource availability , increase raw material cost ( due to scarcity ), or create higher maintenance , repair and replacement costs of damaged assets and equipment .”
The pharmaceutical industry is one of the biggest contributors to global emissions Results from studies show that the pharmaceutical industry has a huge carbon footprint .
“ The designation as one of the biggest contributors to global greenhouse gas ( GHG ) emissions relates to the pharma industry ’ s heavy resource use in product development and production – including large-scale water consumption – and its complex
“ ONE OF THE BIGGEST CONTRIBUTORS TO GLOBAL GREENHOUSE GAS ( GHG ) EMISSIONS RELATES TO THE PHARMA INDUSTRY ’ S COMPLEX SUPPLY CHAINS ”
KATE RODGER HEAD OF CUSTOMER SUCCESS , CERVEST supply chains with large carbon footprints ,” says Rodger . “ Beyond carbon intensity , pharmaceutical operations rely heavily on water in various production processes .”
Water availability is becoming a sustainability challenge that companies are looking to improve . According to data from Water Footprint , in 2020 , pharma manufacturing was responsible for 23 % of global water usage .
“ Furthermore , the 2020 CDP Global Water report showed that biotech , healthcare and pharma companies reported maximum financial impacts of water risks totalling US $ 5.29bn – 38 % higher than the cost of addressing them ( US $ 3.81bn ),” adds Rodger .
Pharmaceutical companies can become more sustainable through an
82 November 2022